Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through ...
ACCESSWIRE· 5 個月前Gilead Sciences, Inc. (Nasdaq:GILD) recently announced that the Gilead Foundation's ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 4 個月前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Direct Relief, Amgen and C/Can Team Up To Improve Access to Breast Cancer Diagnostics and ...
ACCESSWIRE· 5 個月前Direct Relief today announced the launch of a joint, multi-year initiative with Amgen and the ...
Key Insights on Current and Emerging Healthcare Issues
ACCESSWIRE· 5 個月前The Quest Diagnostics Health Trends® series of reports are drawn from our billions of data ...
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
ACCESSWIRE· 5 個月前In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer ...
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 5 個月前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of ...
ACCESSWIRE· 5 個月前The Bristol Myers Squibb Foundation (BMSF), together with Virginia Commonwealth University ...
百濟神州將在 2021 年美國臨床腫瘤學會（ASCO）年會上展示廣泛的臨床產品管線
PR Newswire Asia· 2 年前公司將公佈5款候選藥物針對8種癌症類型在13 項臨床試驗中的結果與設計 將展示3項抗PD-1用藥組合並繼續評估新一代BTK抑制劑百悅澤® 美國麻省劍橋和中國北京 ...
A Beacon of Hope
ACCESSWIRE· 5 個月前Bristol Myers Squibb has a long-standing partnership with The Leukemia & Lymphoma Society (LLS) and has been the top biopharma ...
信達生物聯合禮來製藥宣佈達伯舒（信迪利單抗注射液）聯合化療用於一線治療食管鱗癌獲得國家藥品監督 ...
PR Newswire Asia· 9 個月前美國舊金山、印第安納波利斯和中國蘇州2022年6月21日 /美通社/ -- 信達生物製藥集團（香港聯交所股票代碼：01801），一家致力於研發、生產和銷售腫瘤、自身 ...
